• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虎杖苷通过激活自噬和抑制 NLRP3 炎性体介导的细胞焦亡来防治动脉粥样硬化。

Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.

机构信息

National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.

National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China; Beijing University of Chinese Medicine, Beijing, China.

出版信息

J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2.

DOI:10.1016/j.jep.2023.116304
PMID:36870461
Abstract

ETHNOPHARMACOLOGICAL RELEVANCE

Polydatin is a bioactive ingredient extracted from the roots of the Reynoutria japonica Houtt, and it is a natural precursor of resveratrol. Polydatin is a useful inhibitor of inflammation and acts as a regulator of lipid metabolism. However, the specific mechanisms of action of polydatin in atherosclerosis (AS) remains poorly explained.

AIM OF THE STUDY

The aim of this study was to assess the efficacy of polydatin on inflammation induced by the inflammatory cell death and autophagy in AS.

MATERIALS AND METHODS

Apolipoprotein E knockout (ApoE) mice were fed with a high-fat diet (HFD) for 12 weeks to induce the formation of atherosclerotic lesions. The ApoE mice were then randomly divided into the following six groups: (1) model group, (2) simvastatin group, (3) MCC950 group, (4) low dose polydatin group (Polydatin-L), (5) medium dose polydatin group (Polydatin-M), (6) and high dose polydatin group (Polydatin-H). The C57BL/6J mice were treated as controls and administered a standard chow diet. All mice were gavaged once daily for 8 weeks. The distribution of aortic plaques was observed by En Oil-red-O staining and hematoxylin and eosin staining (H&E). Oil-red-O staining was used to observe lipid content in the aortic sinus plaque; Masson trichrome staining was used to gauge collagen content in the plaque; and immunohistochemistry was used to evaluate smooth muscle actin (α-SMA) and CD68 macrophages marker expression levels in the plaque, which were used to assess the vulnerability index of the plaque. The lipid levels were measured using an enzymatic assay with an automatic biochemical analyzer. The level of inflammation was detected by enzyme-linked-immunosorbent assay (ELISA). Autophagosomes were detected by transmission electron microscopy (TEM). Pyroptosis was detected by terminal deoxynucleotidyl transferase (TdT) dUTP nick-end labeling (TUNEL)/caspase-1 and other proteins related to the expression levels of autophagy and pyroptosis were detected by Western blot analysis.

RESULTS

Nucleotide oligomerization (NOD)-like receptor (NLR) family pyrin domain-containing protein 3 (NLRP3) inflammasome activation leads to pyroptosis, including the cleavage of caspase-1, interleukin (IL)-1β and IL-18 production, and the co-expression of TUNEL/caspase-1-all of these are inhibited by polydatin, whose inhibitory effect is similar to that of MCC950, a specific inhibitor of NLRP3. Further, polydatin decreased the protein expression of NLRP3 and the phosphorylated mammalian target of rapamycin (p-mTOR), and increased the number of autophagosomes as well as the increased the cytoplasmic microtubule-associated protein light chain 3 (LC3)/autophagosome membrane-type LC3 ratio. Moreover, the protein expression levels of p62 decreased, suggesting that polydatin can increase autophagy.

CONCLUSIONS

Polydatin can inhibit the activation of the NLRP3 inflammasome and cleavage of caspase-1, thereby inhibiting pyroptosis and secretion of inflammatory cytokines, and promoting autophagy through NLRP3/mTOR pathway in AS.

摘要

民族药理学相关性

白藜芦醇苷是从虎杖的根中提取的一种生物活性成分,是白藜芦醇的天然前体。白藜芦醇苷是一种有用的炎症抑制剂,可作为脂质代谢调节剂。然而,白藜芦醇苷在动脉粥样硬化(AS)中的具体作用机制仍解释不清。

研究目的

本研究旨在评估白藜芦醇苷对 AS 中炎症细胞死亡和自噬引起的炎症的疗效。

材料和方法

载脂蛋白 E 基因敲除(ApoE)小鼠喂食高脂肪饮食(HFD) 12 周,以诱导动脉粥样硬化病变的形成。然后,将 ApoE 小鼠随机分为以下六组:(1)模型组,(2)辛伐他汀组,(3)MCC950 组,(4)低剂量白藜芦醇苷组(Polydatin-L),(5)中剂量白藜芦醇苷组(Polydatin-M),(6)高剂量白藜芦醇苷组(Polydatin-H)。C57BL/6J 小鼠作为对照并给予标准饲料。所有小鼠每日灌胃一次,持续 8 周。通过 En Oil-red-O 染色和苏木精-伊红(H&E)染色观察主动脉斑块的分布。油红-O 染色观察主动脉窦斑块中的脂质含量;Masson 三色染色观察斑块中的胶原含量;免疫组织化学法评估斑块中平滑肌肌动蛋白(α-SMA)和 CD68 巨噬细胞标志物的表达水平,评估斑块的易损性指数。使用自动生化分析仪的酶法测定血脂水平。通过酶联免疫吸附试验(ELISA)检测炎症水平。通过透射电子显微镜(TEM)检测自噬体。通过末端脱氧核苷酸转移酶(TdT)dUTP 缺口末端标记(TUNEL)/半胱天冬酶-1 检测细胞焦亡,通过 Western blot 分析检测与自噬和细胞焦亡相关的蛋白的表达水平。

结果

核苷酸结合寡聚结构域(NOD)样受体(NLR)家族富含pyrin 结构域蛋白 3(NLRP3)炎症小体的激活导致细胞焦亡,包括半胱天冬酶-1 的裂解、白细胞介素(IL)-1β和 IL-18 的产生以及 TUNEL/半胱天冬酶-1 的共表达,这些均被白藜芦醇苷抑制,其抑制作用与 NLRP3 的特异性抑制剂 MCC950 相似。此外,白藜芦醇苷降低了 NLRP3 和磷酸化哺乳动物雷帕霉素靶蛋白(p-mTOR)的蛋白表达水平,增加了自噬体的数量,以及细胞质微管相关蛋白轻链 3(LC3)/自噬体膜型 LC3 的比值。此外,p62 的蛋白表达水平降低,表明白藜芦醇苷可以增加自噬。

结论

白藜芦醇苷可通过 NLRP3/mTOR 通路抑制 AS 中 NLRP3 炎症小体的激活和半胱天冬酶-1 的裂解,从而抑制细胞焦亡和炎性细胞因子的分泌,并促进自噬。

相似文献

1
Polydatin protects against atherosclerosis by activating autophagy and inhibiting pyroptosis mediated by the NLRP3 inflammasome.虎杖苷通过激活自噬和抑制 NLRP3 炎性体介导的细胞焦亡来防治动脉粥样硬化。
J Ethnopharmacol. 2023 Jun 12;309:116304. doi: 10.1016/j.jep.2023.116304. Epub 2023 Mar 2.
2
Salvianolic acid B inhibits atherosclerosis and TNF-α-induced inflammation by regulating NF-κB/NLRP3 signaling pathway.丹酚酸 B 通过调控 NF-κB/NLRP3 信号通路抑制动脉粥样硬化及 TNF-α 诱导的炎症反应。
Phytomedicine. 2023 Oct;119:155002. doi: 10.1016/j.phymed.2023.155002. Epub 2023 Aug 1.
3
ZeXieYin formula alleviates atherosclerosis by inhibiting the MAPK/NF-κB signaling pathway in APOE-/- mice to attenuate vascular inflammation and increase plaque stability.泽泻饮通过抑制载脂蛋白E基因敲除(APOE-/-)小鼠的丝裂原活化蛋白激酶/核因子κB(MAPK/NF-κB)信号通路来减轻血管炎症并增加斑块稳定性,从而缓解动脉粥样硬化。
J Ethnopharmacol. 2024 Jun 12;327:117969. doi: 10.1016/j.jep.2024.117969. Epub 2024 Mar 2.
4
Xinmaikang (XMK) tablets alleviate atherosclerosis by regulating the SREBP2-mediated NLRP3/ASC/Caspase-1 signaling pathway.心脉康(XMK)片通过调节 SREBP2 介导的 NLRP3/ASC/Caspase-1 信号通路缓解动脉粥样硬化。
J Ethnopharmacol. 2024 Jan 30;319(Pt 2):117240. doi: 10.1016/j.jep.2023.117240. Epub 2023 Sep 28.
5
NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E-Deficient Mice-Brief Report.MCC950对NLRP3炎性小体的抑制作用可减少载脂蛋白E缺乏小鼠的动脉粥样硬化病变发展——简要报告
Arterioscler Thromb Vasc Biol. 2017 Aug;37(8):1457-1461. doi: 10.1161/ATVBAHA.117.309575. Epub 2017 Jun 8.
6
Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.岩藻聚糖硫酸酯通过增强 p62/SQSTM1 依赖性自噬来抑制 NLRP3 炎性小体激活,从而缓解动脉粥样硬化。
Oxid Med Cell Longev. 2020 Aug 6;2020:3186306. doi: 10.1155/2020/3186306. eCollection 2020.
7
Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis.伴侣蛋白介导的自噬缺陷促进炎症和动脉粥样硬化。
Circ Res. 2021 Dec 3;129(12):1141-1157. doi: 10.1161/CIRCRESAHA.121.318908. Epub 2021 Oct 27.
8
Guizhitongluo Tablet inhibits atherosclerosis and foam cell formation through regulating Piezo1/NLRP3 mediated macrophage pyroptosis.龟芪通络片通过调控 Piezo1/NLRP3 介导的巨噬细胞焦亡抑制动脉粥样硬化及泡沫细胞形成。
Phytomedicine. 2024 Sep;132:155827. doi: 10.1016/j.phymed.2024.155827. Epub 2024 Jun 13.
9
[Mechanism of total flavonoids of Ziziphora clinopodioides in improving atherosclerosis by regulating PI3K/Akt/mTOR pathway].[新疆新塔花总黄酮通过调控PI3K/Akt/mTOR通路改善动脉粥样硬化的机制]
Zhongguo Zhong Yao Za Zhi. 2023 Jan;48(2):465-471. doi: 10.19540/j.cnki.cjcmm.20220726.403.
10
The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages.选择性 NLRP3 抑制剂 MCC950 通过减弱巨噬细胞中的炎症和细胞焦亡来阻碍动脉粥样硬化的发展。
Sci Rep. 2021 Sep 29;11(1):19305. doi: 10.1038/s41598-021-98437-3.

引用本文的文献

1
The relationship between programmed cell death and vascular calcification.程序性细胞死亡与血管钙化之间的关系。
Front Cardiovasc Med. 2025 Jul 10;12:1549857. doi: 10.3389/fcvm.2025.1549857. eCollection 2025.
2
Resveratrol Attenuates CSF Markers of Neurodegeneration and Neuroinflammation in Individuals with Alzheimer's Disease.白藜芦醇可减轻阿尔茨海默病患者神经退行性变和神经炎症的脑脊液标志物水平。
Int J Mol Sci. 2025 May 23;26(11):5044. doi: 10.3390/ijms26115044.
3
The NLRP3 inflammasome: a therapeutic target of phytochemicals in treating atherosclerosis (a systematic review).
NLRP3炎性小体:植物化学物质治疗动脉粥样硬化的治疗靶点(系统评价)
Front Immunol. 2025 May 15;16:1568722. doi: 10.3389/fimmu.2025.1568722. eCollection 2025.
4
The Regulatory Role of NcRNAs in Pyroptosis and Disease Pathogenesis.非编码RNA在细胞焦亡及疾病发病机制中的调控作用
Cell Biochem Biophys. 2025 Apr 18. doi: 10.1007/s12013-025-01720-7.
5
Polydatin protects against leukemia by inducing apoptosis and activating autophagy via p38-MAPK pathway.白藜芦醇苷通过p38丝裂原活化蛋白激酶(MAPK)途径诱导凋亡并激活自噬,从而对白血病起到保护作用。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 14. doi: 10.1007/s00210-025-04160-5.
6
Polydatin combined with hawthorn flavonoids alleviate high fat diet induced atherosclerosis by remodeling the gut microbiota and glycolipid metabolism.虎杖苷联合山楂黄酮通过重塑肠道微生物群和糖脂代谢减轻高脂饮食诱导的动脉粥样硬化。
Front Pharmacol. 2025 Mar 3;16:1515485. doi: 10.3389/fphar.2025.1515485. eCollection 2025.
7
Potential of Polydatin Against Ischemia-Reperfusion Injury: New Insights from Pharmacological-Pathological Mechanism Associations.虎杖苷抗缺血再灌注损伤的潜力:药理学 - 病理机制关联的新见解
Drug Des Devel Ther. 2025 Mar 6;19:1585-1594. doi: 10.2147/DDDT.S508851. eCollection 2025.
8
Macrophage pyroptosis in atherosclerosis: therapeutic potential.动脉粥样硬化中的巨噬细胞焦亡:治疗潜力
Acta Biochim Biophys Sin (Shanghai). 2025 Feb 14;57(6):857-870. doi: 10.3724/abbs.2025004.
9
Polydatin protects against DSS-induced ulcerative colitis via Nrf2/Slc7a11/Gpx4-dependent inhibition of ferroptosis signalling activation.白藜芦醇苷通过Nrf2/Slc7a11/Gpx4依赖性抑制铁死亡信号激活来预防右旋糖酐硫酸钠诱导的溃疡性结肠炎。
Front Pharmacol. 2025 Jan 14;15:1513020. doi: 10.3389/fphar.2024.1513020. eCollection 2024.
10
Genistein-3'-sodium sulfonate suppresses NLRP3-mediated cell pyroptosis after cerebral ischemia.染料木黄酮-3'-磺酸钠抑制脑缺血后NLRP3介导的细胞焦亡。
Metab Brain Dis. 2025 Jan 14;40(1):99. doi: 10.1007/s11011-025-01530-z.